CONSORT Reporting Tool
3 Results
- Erratum
Erratum to “Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets better” [J Clin Epidemiol 2010;63:813–814]
Journal of Clinical EpidemiologyVol. 64Issue 3p343Published online: January 3, 2011- Maarten Boers
Cited in Scopus: 0The first paragraph of the above-mentioned commentary was published without the proper reference citations. Below is the corrected paragraph with reference citations included: - Original ArticleOpen Access
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials
Journal of Clinical EpidemiologyVol. 63Issue 8p834–840Published online: March 26, 2010- Kenneth F. Schulz
- Douglas G. Altman
- David Moher
- CONSORT Group
Cited in Scopus: 633Randomised controlled trials, when appropriately designed, conducted, and reported, represent the gold standard in evaluating healthcare interventions. However, randomised trials can yield biased results if they lack methodological rigour [1]. To assess a trial accurately, readers of a published report need complete, clear, and transparent information on its methodology and findings. Unfortunately, attempted assessments frequently fail because authors of many trial reports neglect to provide lucid and complete descriptions of that critical information [2–4]. - Original ArticleOpen Access
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
Journal of Clinical EpidemiologyVol. 63Issue 8e1–e37Published online: March 26, 2010- David Moher
- Sally Hopewell
- Kenneth F. Schulz
- Victor Montori
- Peter C. Gøtzsche
- P.J. Devereaux
- and others
Cited in Scopus: 1368Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias.